IT-05 ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION

INTRODUCTION: Recurrent high grade glioma (rHGG) remains one of the most deadly cancers. Investigational agents Toca 511, a retroviral replicating vector, and Toca FC (extended-release 5-FC) are used in combination to target residual tumor at the time of resection. METHODS: This study (NCT01470794)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cloughesy, Timothy F., Kesari, Santosh, Kalkanis, Steven, Mikkelsen, Tom, Landolfi, Joseph, Elder, J. Bradley, Liau, Linda M., Chen, Clark C., Bloomfield, Stephen, Piccioni, David, Chiocca, E. Antonio, Foltz, Greg, Robbins, Joan M., Ostertag, Derek, Jolly, Doug J., Ibañez, Carlos, Pertschuk, Dan, Pan, Christine, Vogelbaum, Michael A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218255/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak